Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.07 USD | +4.05% | +15.06% | +7.77% |
May. 13 | Harrow Health Q1 Core Net Loss Widens, Revenue Increases -- Shares Rise After-Hours | MT |
Apr. 11 | Craig-Hallum Starts Harrow With Buy Rating, $24 Price Target | MT |
Financials (USD)
Sales 2024 * | 183M | Sales 2025 * | 250M | Capitalization | 427M |
---|---|---|---|---|---|
Net income 2024 * | -12M | Net income 2025 * | 22M | EV / Sales 2024 * | 2.33 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.71 x |
P/E ratio 2024 * |
-35
x | P/E ratio 2025 * |
21.1
x | Employees | 315 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.92% |
Latest transcript on Harrow, Inc.
1 day | +4.05% | ||
1 week | +15.06% | ||
Current month | +18.45% | ||
1 month | -4.58% | ||
3 months | +4.87% | ||
6 months | -5.92% | ||
Current year | +7.77% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Baum
CEO | Chief Executive Officer | 51 | 05-12-31 |
Andrew Boll
DFI | Director of Finance/CFO | 41 | 11-11-30 |
Jamie Webb
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Baum
CEO | Chief Executive Officer | 51 | 05-12-31 |
Director/Board Member | 65 | Jan. 25 | |
Adrienne Graves
BRD | Director/Board Member | 69 | Jan. 25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +3.39% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 12.07 | +4.05% | 832,176 |
24-05-10 | 11.6 | +12.73% | 1,125,325 |
24-05-09 | 10.29 | -0.29% | 226,924 |
24-05-08 | 10.32 | -5.67% | 267,782 |
24-05-07 | 10.94 | +4.29% | 262,710 |
Delayed Quote OTC Markets, May 13, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.77% | 427M | |
+29.98% | 682B | |
+30.34% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+4.07% | 285B | |
+16.21% | 240B | |
+9.66% | 209B | |
-6.83% | 203B | |
+7.09% | 165B |
- Stock Market
- Equities
- HROW Stock